Compare JPMorgan Equity Premium Income ETF (JEPI) vs UnitedHealth Group Inc (UNH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
JPMorgan Equity Premium Income ETF vs UnitedHealth Group Inc — how do they compare? JPMorgan Equity Premium Income ETF trades at $56.48, while UnitedHealth Group Inc trades at $423.04 (market cap $386.95B). The key difference: UnitedHealth Group Inc pays a 2.18% dividend while JPMorgan Equity Premium Income ETF pays none, and UnitedHealth Group Inc is trading nearer its 52-week high, JPMorgan Equity Premium Income ETF nearer its low. Which is the better fit depends on your goals.
| JEPI | UNH | |
|---|---|---|
Sector | Income / Options Overlay | Health |
52-Week High | $59.88 | $431.68 |
52-Week Low | $55.29 | $237.77 |
Market Cap | — | $386.95B |
Enterprise Value | — | $433.64B |
Dividend Yield | — | 2.18% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
JEPI trades at $56.54, showing minimal daily movement with a slight decline of 0.02%. The ETF's technical indicators signal a bearish trend with moving averages showing selling pressure, though oscillators remain neutral. Recent news highlights concerns about JEPI's underperformance compared to the S&P 500 and peer covered-call ETFs, with criticism of its sector allocation and synthetic call strategy.
The outlook remains cautious as JEPI's covered-call strategy caps upside potential during bull markets while providing high income. Key risks include tax inefficiency in taxable accounts and tracking error. Investors seeking monthly income may find value, but total return potential appears limited compared to broader market indices given current market conditions.
UnitedHealth Group (UNH) trades at $426.09, up 0.64% today, with strong technical momentum indicated by bullish moving averages and a consensus analyst price target of $466.41. The company has consistently beaten earnings expectations in recent quarters, with Q2 2026 EPS of $6.38 surpassing estimates of $4.94. Revenue reached $447.57 billion in 2025, though net income margin declined to 2.68%. Recent news highlights strategic moves to reduce pediatric prior authorizations and ongoing shareholder returns via dividends and buybacks.
UNH presents a favorable outlook supported by analyst optimism (82.7% buy ratings) and structural industry tailwinds like aging demographics. Key risks include regulatory scrutiny, as seen in recent state lawsuits, and margin pressure from rising costs. The stock's valuation at a P/E of 32.09 requires sustained earnings growth to justify further upside, making execution on cost management and growth initiatives critical for investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About JPMorgan Equity Premium Income ETF
JEPI is an actively managed ETF that seeks to deliver monthly income and stock market exposure with lower volatility. It combines an equity portfolio with an options strategy to generate steady premiums.
Read more on JEPI →About UnitedHealth Group Inc
UnitedHealth Group is one of the largest private health insurers, providing medical benefits to 50 million members globally, including 5 million outside the U.S. at the end of 2021. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in managed care. Along with its insurance assets, UnitedHealth's continued investments in its Optum franchises have created a healthcare services colossus that spans everything from medical and pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Read more on UNH →
